choline has been researched along with Cardiovascular Stroke in 20 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study demonstrated that RGS4 promoted cardiac fibrosis and attenuated the anti-cardiac fibrosis of choline." | 8.02 | The association between RGS4 and choline in cardiac fibrosis. ( Du, Z; Fan, Z; Guo, J; Hang, P; Li, W; Sun, Y; Yu, J; Zhao, X, 2021) |
| "To clarify the role of cholin- and histaminergic shifts in the onset of circulatory and functional gastric disturbances associated with erosive-ulcer gastroduodenal lesions in myocardial infarction (MI)." | 7.73 | [Choline- and histaminergic shifts as a trigger of gastroduodenal erosive-ulcer lesions in myocardial infarction]. ( Chernin, VV; Osadchiĭ, VA, 2005) |
| "Choline has been identified as a promising marker of coronary inflammation, plaque destabilisation and ischaemia." | 5.35 | Choline for diagnosis and prognostication of acute coronary syndromes in the Emergency Department. ( Body, R; Carley, S; Ferguson, J; Griffith, CA; Keevil, B; Mackway-Jones, K; McDowell, G, 2009) |
| "We sought to study relations of plasma choline and its metabolite betaine to long-term risk of acute myocardial infarction (AMI) and all-cause mortality according to smoking status, in patients undergoing coronary angiography for stable angina pectoris." | 5.20 | Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris. ( Bleie, Ø; Ebbing, M; Nygård, O; Pedersen, ER; Schartum-Hansen, H; Seifert, R; Strand, E; Svingen, GF; Ueland, PM, 2015) |
| "This study demonstrated that RGS4 promoted cardiac fibrosis and attenuated the anti-cardiac fibrosis of choline." | 4.02 | The association between RGS4 and choline in cardiac fibrosis. ( Du, Z; Fan, Z; Guo, J; Hang, P; Li, W; Sun, Y; Yu, J; Zhao, X, 2021) |
| "The M(3) subtype of muscarinic acetylcholine receptors (M(3)-mAChR) plays a protective role in myocardial ischemia and microRNAs (miRNAs) participate in many cardiac pathophysiological processes, including ischemia-induced cardiac injury." | 3.78 | M3 subtype of muscarinic acetylcholine receptor promotes cardioprotection via the suppression of miR-376b-5p. ( Du, Z; Fan, K; Fan, Y; Guo, F; Guo, Y; Hou, Y; Huo, R; Liu, Y; Pan, Z; Qi, H; Wang, N; Wang, S; Xie, J; Zhang, Y; Zhao, H, 2012) |
| "Compared to the control group, pretreatment with choline significantly decreased ischaemia-induced arrhythmias, reduced the total number of ventricular premature beats, the duration of ventricular tachycardia episodes and markedly reduced I/R-induced infarct size." | 3.76 | Activation of cardiac muscarinic M3 receptors induces delayed cardioprotection by preserving phosphorylated connexin43 and up-regulating cyclooxygenase-2 expression. ( Chen, X; Du, Z; Liu, Y; Lu, Y; Pan, Z; Su, Y; Yang, B; Yang, L; Zhang, Y; Zhao, J, 2010) |
| "To clarify the role of cholin- and histaminergic shifts in the onset of circulatory and functional gastric disturbances associated with erosive-ulcer gastroduodenal lesions in myocardial infarction (MI)." | 3.73 | [Choline- and histaminergic shifts as a trigger of gastroduodenal erosive-ulcer lesions in myocardial infarction]. ( Chernin, VV; Osadchiĭ, VA, 2005) |
| "We found that choline relieved myocardial injuries during ischemia or under oxidative stress, which was achieved by correcting hemodynamic impairment, diminishing ventricular arrhythmias and protecting cardiomyocytes from apoptotic death." | 3.73 | Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors. ( Han, H; Lin, H; Liu, Y; Wang, H; Wang, Z; Xu, C; Yang, B, 2005) |
| "Choline has been identified as a promising marker of coronary inflammation, plaque destabilisation and ischaemia." | 1.35 | Choline for diagnosis and prognostication of acute coronary syndromes in the Emergency Department. ( Body, R; Carley, S; Ferguson, J; Griffith, CA; Keevil, B; Mackway-Jones, K; McDowell, G, 2009) |
| "Choline was not a marker for myocardial necrosis but indicated high-risk unstable angina in patients without acute myocardial infarction (sensitivity 86." | 1.32 | Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. ( Danne, O; Frei, U; Lueders, C; Lufft, H; Möckel, M; Mügge, C; Müller, C; Zschunke, GA, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 5 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C | 1 |
| Sun, Z | 1 |
| Shali, S | 1 |
| Mei, Z | 1 |
| Chang, S | 1 |
| Mo, H | 1 |
| Xu, L | 1 |
| Pu, Y | 1 |
| Guan, H | 1 |
| Chen, GC | 1 |
| Qi, Q | 1 |
| Quan, Z | 1 |
| Qi, J | 1 |
| Yao, K | 1 |
| Dai, Y | 1 |
| Zheng, Y | 1 |
| Ge, J | 1 |
| Yoshida, Y | 2 |
| Shimizu, I | 1 |
| Shimada, A | 1 |
| Nakahara, K | 1 |
| Yanagisawa, S | 1 |
| Kubo, M | 1 |
| Fukuda, S | 1 |
| Ishii, C | 1 |
| Yamamoto, H | 1 |
| Ishikawa, T | 1 |
| Kano, K | 1 |
| Aoki, J | 1 |
| Katsuumi, G | 1 |
| Suda, M | 1 |
| Ozaki, K | 1 |
| Okuda, S | 1 |
| Ohta, S | 1 |
| Okamoto, S | 1 |
| Minokoshi, Y | 1 |
| Oda, K | 1 |
| Sasaoka, T | 1 |
| Abe, M | 1 |
| Sakimura, K | 1 |
| Kubota, Y | 1 |
| Yoshimura, N | 1 |
| Kajimura, S | 1 |
| Zuriaga, M | 1 |
| Walsh, K | 1 |
| Soga, T | 1 |
| Minamino, T | 1 |
| Van Parys, A | 1 |
| Lysne, V | 1 |
| Svingen, GFT | 1 |
| Ueland, PM | 2 |
| Dhar, I | 1 |
| Øyen, J | 1 |
| Dierkes, J | 1 |
| Nygård, OK | 1 |
| Wang, AP | 1 |
| Suryavanshi, T | 1 |
| Marcucci, M | 1 |
| Fong, C | 1 |
| Whitton, AC | 1 |
| Reddy, KKV | 1 |
| Guo, J | 1 |
| Hang, P | 1 |
| Yu, J | 1 |
| Li, W | 1 |
| Zhao, X | 1 |
| Sun, Y | 1 |
| Fan, Z | 1 |
| Du, Z | 3 |
| Haissman, JM | 1 |
| Haugaard, AK | 1 |
| Ostrowski, SR | 1 |
| Berge, RK | 1 |
| Hov, JR | 1 |
| Trøseid, M | 1 |
| Nielsen, SD | 1 |
| Zhong, Z | 1 |
| Liu, J | 1 |
| Zhang, Q | 1 |
| Zhong, W | 1 |
| Li, B | 1 |
| Li, C | 1 |
| Liu, Z | 1 |
| Yang, M | 1 |
| Zhao, P | 1 |
| Sinha, A | 1 |
| Ma, Y | 1 |
| Scherzer, R | 1 |
| Rahalkar, S | 1 |
| Neilan, BD | 1 |
| Crane, H | 1 |
| Drozd, D | 1 |
| Martin, J | 1 |
| Deeks, SG | 1 |
| Hunt, P | 1 |
| Hsue, PY | 1 |
| Schartum-Hansen, H | 1 |
| Pedersen, ER | 1 |
| Svingen, GF | 1 |
| Seifert, R | 1 |
| Ebbing, M | 1 |
| Strand, E | 1 |
| Bleie, Ø | 1 |
| Nygård, O | 1 |
| Body, R | 1 |
| Griffith, CA | 1 |
| Keevil, B | 1 |
| McDowell, G | 1 |
| Carley, S | 1 |
| Ferguson, J | 1 |
| Mackway-Jones, K | 1 |
| Wang, YP | 1 |
| Hang, PZ | 1 |
| Sun, LH | 1 |
| Zhang, Y | 3 |
| Zhao, JL | 1 |
| Pan, ZW | 1 |
| Ji, HR | 1 |
| Wang, LA | 1 |
| Bi, H | 1 |
| Du, ZM | 1 |
| Zhao, J | 1 |
| Su, Y | 1 |
| Pan, Z | 2 |
| Yang, L | 1 |
| Chen, X | 1 |
| Liu, Y | 4 |
| Lu, Y | 1 |
| Yang, B | 2 |
| Muller, O | 1 |
| Barbato, E | 1 |
| De Bruyne, B | 1 |
| Bartunek, J | 1 |
| Giuliani, D | 1 |
| Ottani, A | 1 |
| Altavilla, D | 1 |
| Bazzani, C | 1 |
| Squadrito, F | 1 |
| Guarini, S | 1 |
| Searle, J | 1 |
| Danne, O | 2 |
| Müller, C | 2 |
| Mockel, M | 2 |
| Guo, Y | 1 |
| Qi, H | 1 |
| Fan, K | 1 |
| Wang, S | 1 |
| Zhao, H | 1 |
| Fan, Y | 1 |
| Xie, J | 1 |
| Guo, F | 1 |
| Hou, Y | 1 |
| Wang, N | 1 |
| Huo, R | 1 |
| Lueders, C | 1 |
| Mügge, C | 1 |
| Zschunke, GA | 1 |
| Lufft, H | 1 |
| Frei, U | 1 |
| Jing, YH | 1 |
| Sun, HL | 1 |
| Li, HL | 1 |
| Yang, BF | 1 |
| Chernin, VV | 1 |
| Osadchiĭ, VA | 1 |
| Lin, H | 1 |
| Xu, C | 1 |
| Wang, H | 1 |
| Han, H | 1 |
| Wang, Z | 1 |
3 reviews available for choline and Cardiovascular Stroke
| Article | Year |
|---|---|
Biomarkers of vulnerable plaque: the missing link with ischemia.
Topics: Albumins; Biomarkers; Choline; Coronary Artery Disease; Cystatin C; Fatty Acids, Nonesterified; Huma | 2010 |
Melanocortins and the cholinergic anti-inflammatory pathway.
Topics: Animals; Choline; Humans; Inflammation; Melanocortins; Myocardial Infarction; Myocardial Reperfusion | 2010 |
Biomarkers in acute coronary syndrome and percutaneous coronary intervention.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acute Coronary Syndrome; Angioplasty, Balloon, Coron | 2011 |
1 trial available for choline and Cardiovascular Stroke
| Article | Year |
|---|---|
Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris.
Topics: Aged; Angina, Stable; Betaine; Biomarkers; C-Reactive Protein; Choline; Coronary Angiography; Corona | 2015 |
16 other studies available for choline and Cardiovascular Stroke
| Article | Year |
|---|---|
The gut microbiome and microbial metabolites in acute myocardial infarction.
Topics: Choline; Feces; Gastrointestinal Microbiome; Humans; Myocardial Infarction; RNA, Ribosomal, 16S | 2022 |
Brown adipose tissue dysfunction promotes heart failure via a trimethylamine N-oxide-dependent mechanism.
Topics: Adipocytes, Brown; Adipose Tissue, Brown; Animals; Choline; Heart Failure; Methylamines; Mice; Myoca | 2022 |
Dietary choline is related to increased risk of acute myocardial infarction in patients with stable angina pectoris.
Topics: Aged; Angina, Stable; Choline; Diet; Female; Humans; Male; Middle Aged; Myocardial Infarction; Norwa | 2020 |
Radiation Necrosis Following Stereotactic Radiosurgery for Trigeminal Neuralgia.
Topics: Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Creatine; Diagnostic Err | 2020 |
The association between RGS4 and choline in cardiac fibrosis.
Topics: Animals; Choline; Fibroblasts; Fibrosis; Gene Silencing; Male; MAP Kinase Signaling System; Mice; My | 2021 |
Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
Topics: Adult; Betaine; Biomarkers; Blood Platelets; Cardiovascular Diseases; Carnitine; Choline; Cross-Sect | 2017 |
Targeted metabolomic analysis of plasma metabolites in patients with coronary heart disease in southern China.
Topics: Aged; Angina, Stable; Angina, Unstable; Biomarkers; Carnitine; China; Choline; Chromatography, Liqui | 2019 |
Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV -Infected Adults.
Topics: Adult; Antiretroviral Therapy, Highly Active; Atherosclerosis; Betaine; Carnitine; Carotid Artery Di | 2019 |
Choline for diagnosis and prognostication of acute coronary syndromes in the Emergency Department.
Topics: Acute Coronary Syndrome; Aged; Choline; Early Diagnosis; Emergency Service, Hospital; Female; Follow | 2009 |
M3 muscarinic acetylcholine receptor is associated with beta-catenin in ventricular myocytes during myocardial infarction in the rat.
Topics: Animals; beta Catenin; Choline; Heart Ventricles; Male; Myocardial Infarction; Myocardial Ischemia; | 2009 |
Activation of cardiac muscarinic M3 receptors induces delayed cardioprotection by preserving phosphorylated connexin43 and up-regulating cyclooxygenase-2 expression.
Topics: Animals; Arrhythmias, Cardiac; Choline; Connexin 43; Cyclooxygenase 2; Disease Models, Animal; Hemod | 2010 |
M3 subtype of muscarinic acetylcholine receptor promotes cardioprotection via the suppression of miR-376b-5p.
Topics: Animals; Calcium; Cell Line; Choline; Down-Regulation; Gene Expression Regulation; Ischemia; Male; M | 2012 |
Prognostic implications of elevated whole blood choline levels in acute coronary syndromes.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; Biomarkers; Choline; Female; | 2003 |
[Relationship between M3 receptor and myocyte apoptosis induced by acute myocardial infarction].
Topics: Animals; Apoptosis; Choline; fas Receptor; Male; Malondialdehyde; Myocardial Infarction; Myocardium; | 2004 |
[Choline- and histaminergic shifts as a trigger of gastroduodenal erosive-ulcer lesions in myocardial infarction].
Topics: Adolescent; Adult; Aged; Choline; Disease Progression; Female; Histamine; Humans; Hyperhomocysteinem | 2005 |
Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors.
Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Calcium; Cells, Cultured; Choline; Coronary Disease; Cytop | 2005 |